Seeing Is Believing
Currently out of the existing stock ratings of Lawrence Keusch, 108 are a BUY (93.91%), 6 are a HOLD (5.22%), 1 are a SELL (0.87%).
Analyst Lawrence Keusch, currently employed carries an average stock price target met ratio of 75.83% that have a potential upside of 18.39% achieved within 269 days.
Lawrence Keusch’s has documented 192 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on BDX, Becton Dickinson and Company at 04-Aug-2023.
Analyst best performing recommendations are on HAE (HAEMONETICS).
The best stock recommendation documented was for BDX (BECTON DICKINSON AND COMPANY) at 2/7/2020. The price target of $232.2 was fulfilled within 4 days with a profit of $6.18 (2.73%) receiving and performance score of 6.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
$34
1 years 3 months 27 days ago
(25-Jul-2023)
5/10 (50%)
$11.59 (51.72%)
102
Hold
$25
$6.32 (33.83%)
$28
1 years 5 months ago
(21-Jun-2023)
5/5 (100%)
$-0.61 (-2.38%)
153
Buy
$31
$12.32 (65.95%)
$30
1 years 5 months 30 days ago
(22-May-2023)
6/7 (85.71%)
$7.45 (31.63%)
396
Sell
$24
$-2.79 (-10.41%)
$28
2 years 1 months 10 days ago
(11-Oct-2022)
2/4 (50%)
$3.54 (12.24%)
19
Hold
$40
$21.32 (114.13%)
$45
3 years 18 days ago
(03-Nov-2021)
3/5 (60%)
$3.98 (11.05%)
100
What Year was the first public recommendation made by Lawrence Keusch?